Get Full access to Top 1000 data, subscribe from only €29

Tri-Supply

Add to comparison

Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007. It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product. It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.

Financial Data

31st Dec 15 Source: CRO
- €172.6 million turnover
- -€82 profit
- 0 employees
- Auditor: Ernst & Young
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 14 Source: CRO
- €184.6 million turnover
- €197 profit
- Auditor: Ernst & Young
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
4 more years available »